CN1308334C - Extraction of phosphatidyl serine from brains of animals - Google Patents
Extraction of phosphatidyl serine from brains of animals Download PDFInfo
- Publication number
- CN1308334C CN1308334C CNB2004100242257A CN200410024225A CN1308334C CN 1308334 C CN1308334 C CN 1308334C CN B2004100242257 A CNB2004100242257 A CN B2004100242257A CN 200410024225 A CN200410024225 A CN 200410024225A CN 1308334 C CN1308334 C CN 1308334C
- Authority
- CN
- China
- Prior art keywords
- phosphatidylserine
- extraction
- remove
- evaporate
- stir
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 210000004556 brain Anatomy 0.000 title claims abstract description 48
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 title claims abstract description 47
- 238000000605 extraction Methods 0.000 title claims abstract description 21
- 241001465754 Metazoa Species 0.000 title claims abstract description 20
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 95
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims abstract description 90
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 30
- 238000003756 stirring Methods 0.000 claims abstract description 30
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 28
- 239000000284 extract Substances 0.000 claims abstract description 22
- 239000000243 solution Substances 0.000 claims abstract description 19
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 18
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000006228 supernatant Substances 0.000 claims abstract description 12
- 239000007864 aqueous solution Substances 0.000 claims abstract description 11
- 239000000843 powder Substances 0.000 claims abstract description 11
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 claims abstract description 7
- 239000003921 oil Substances 0.000 claims abstract description 7
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 8
- 239000002245 particle Substances 0.000 claims description 8
- 239000001632 sodium acetate Substances 0.000 claims description 8
- 235000017281 sodium acetate Nutrition 0.000 claims description 8
- 238000001556 precipitation Methods 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 3
- 125000002252 acyl group Chemical group 0.000 claims 3
- 229960004249 sodium acetate Drugs 0.000 claims 3
- 239000007788 liquid Substances 0.000 claims 2
- 230000002490 cerebral effect Effects 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000010025 steaming Methods 0.000 claims 1
- -1 inositol phospholipids Chemical class 0.000 abstract description 16
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 abstract description 13
- 229960000367 inositol Drugs 0.000 abstract description 13
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 abstract description 13
- 239000008187 granular material Substances 0.000 abstract description 11
- 239000002244 precipitate Substances 0.000 abstract description 11
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract description 3
- VIGBIBDAVDHOTP-UHFFFAOYSA-M sodium;ethanol;acetate Chemical compound [Na+].CCO.CC([O-])=O VIGBIBDAVDHOTP-UHFFFAOYSA-M 0.000 abstract description 3
- 241000283690 Bos taurus Species 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 11
- 229960004756 ethanol Drugs 0.000 description 11
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 8
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- 239000000787 lecithin Substances 0.000 description 8
- 229940067606 lecithin Drugs 0.000 description 8
- 235000010445 lecithin Nutrition 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- CFWRDBDJAOHXSH-SECBINFHSA-N 2-azaniumylethyl [(2r)-2,3-diacetyloxypropyl] phosphate Chemical compound CC(=O)OC[C@@H](OC(C)=O)COP(O)(=O)OCCN CFWRDBDJAOHXSH-SECBINFHSA-N 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000283074 Equus asinus Species 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- 241001494479 Pecora Species 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- ZXVOCOLRQJZVBW-UHFFFAOYSA-N azane;ethanol Chemical compound N.CCO ZXVOCOLRQJZVBW-UHFFFAOYSA-N 0.000 description 3
- 239000012535 impurity Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- 241000283086 Equidae Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000002035 hexane extract Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002893 slag Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 238000010257 thawing Methods 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 102000011420 Phospholipase D Human genes 0.000 description 1
- 108090000553 Phospholipase D Proteins 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000007012 clinical effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229960000935 dehydrated alcohol Drugs 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000011056 potassium acetate Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 239000010414 supernatant solution Substances 0.000 description 1
Landscapes
- Fats And Perfumes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明提供一种从动物脑提取磷脂酰丝氨酸的方法,a.先将干燥动物脑碎成颗粒,再向颗粒中加入丙酮,搅拌萃取,除去含有干脑粒中胆固醇和油类的丙酮上清液,残渣蒸干;b.向蒸干的残渣加入正己烷或乙醇或氨水乙醇溶液,搅拌萃取,除去含有磷脂复合物的萃取液,残渣蒸干;c.向蒸干的残渣加入乙醚,搅拌萃取,萃取液经蒸浓后加入碱性水溶液,搅拌、冻结、解冻,滤除沉淀,进一步除去剩余的磷脂,然后将上清液调pH=3~6,蒸除乙醚,再蒸干得粗磷脂酰丝氨酸。再将粗磷脂酰丝氨酸干粉溶于正己烷中,再加入醋酸钠乙醇溶液,搅拌、静置分层,除去含有肌醇磷脂的下层,上部正己烷减压蒸干得高纯度磷脂酰丝氨酸。The present invention provides a method for extracting phosphatidylserine from animal brains, a. First, crush the dried animal brains into granules, then add acetone to the granules, stir and extract, and remove the acetone supernatant containing cholesterol and oils in the dry brain granules b. Add n-hexane or ethanol or ammonia water ethanol solution to the evaporated residue, stir and extract, remove the extract containing phospholipid complex, and evaporate the residue; c. Add ether to the evaporated residue, stir Extraction, the extract is evaporated and concentrated, then added to an alkaline aqueous solution, stirred, frozen, thawed, filtered to remove the precipitate, and further removed the remaining phospholipids, then the supernatant was adjusted to pH=3~6, diethyl ether was evaporated, and then evaporated to dryness to obtain crude Phosphatidylserine. Then dissolve the crude phosphatidylserine dry powder in n-hexane, then add sodium acetate ethanol solution, stir, let stand to separate layers, remove the lower layer containing inositol phospholipids, and evaporate the upper part of n-hexane to dryness under reduced pressure to obtain high-purity phosphatidylserine.
Description
技术领域technical field
本发明涉及家畜动物脑提取磷脂酰丝氨酸的方法,尤其适合于以牛、羊、兔、马、驴等家畜动物脑为原料的磷脂酰丝氨酸的提取方法。The invention relates to a method for extracting phosphatidylserine from the brains of livestock animals, and is especially suitable for extracting phosphatidylserine from the brains of livestock animals such as cattle, sheep, rabbits, horses and donkeys.
背景技术Background technique
牛脑磷脂酰丝氨酸(PS)有增强记忆,抗老年性痴呆等作用已经被国内外动物实验和临床验证,参见、刘平.磷脂酰丝氨酸的药理及临床应用研究进展,国外医学药学分册1981,18(4),207-230。但以牛脑为原料,批量提取生产PS有困难。李斯M.B等(1981)和阿比德等(1998)综述PS的层析制备和分析方法,制备方法及其复杂。参见李斯MB等,磷脂和甾类分析和制备(Lees MBet al.preparation and Analysis of phosphatides Lipids and steroids,1981,328-345)和阿比德等,色谱学B集1998,(717)279-293(Abidi,SL et al.Journal ofchromatography B,717(1988)279-293).陈苏等研究高压液相制备方法,虽然可用于试剂制备,但产量实在有限。参见陈苏等.色谱学B集1995,(666)178-182(Su chen et al.Journal of chromatography B.666,1995,178-182)。美国用大豆磷脂和L-丝氨酸在磷脂酶D作用下合成PS,并研究成功提取制备方法,参见美国专利5700668(united states patent 5700668)。但这种用大豆磷脂合成的PS其临床效果远不如牛脑提取的PS。经过许多重复实验检证,该方法也不适合于牛等动物脑提取PS。Bovine brain phosphatidylserine (PS) has the effects of enhancing memory and anti-senile dementia, which have been verified by animal experiments and clinical trials at home and abroad. 18(4), 207-230. However, it is difficult to extract and produce PS in batches using bovine brain as raw material. Lees M.B et al. (1981) and Abid et al. (1998) reviewed the chromatographic preparation and analysis methods of PS, and the preparation methods were extremely complicated. See Lees MB et al. preparation and Analysis of phosphatides Lipids and steroids (Lees MB et al. preparation and Analysis of phosphatides Lipids and steroids, 1981, 328-345) and Abed et al. Chromatography B Collection 1998, (717) 279-293 (Abidi, SL et al. Journal of chromatography B, 717 (1988) 279-293). Chen Su and others studied the high-pressure liquid phase preparation method. Although it can be used for reagent preparation, the output is really limited. See Chen Su et al. Chromatography B Collection 1995, (666) 178-182 (Su chen et al. Journal of chromatography B.666, 1995, 178-182). The United States uses soybean phospholipids and L-serine to synthesize PS under the action of phospholipase D, and studies the successful extraction and preparation method, see US Patent 5700668 (united states patent 5700668). However, the clinical effect of PS synthesized from soybean phospholipids is far inferior to PS extracted from bovine brain. After many repeated experiments, this method is not suitable for extracting PS from the brains of cattle and other animals.
我国畜牧养殖正在快速发展,肉牛屠宰量很大,牛脑随牛头廉价销出,有的食用,有的扔掉。近些年来,我们一直从事牛脑PS的提取研究,为牛脑的增值利用开辟新路子、摸索成功可工业生产的牛脑PS提取制备方法。my country's animal husbandry is developing rapidly, and a large amount of beef cattle are slaughtered. The brains of the cattle are sold at a low price along with the heads. Some are eaten, and some are thrown away. In recent years, we have been engaged in the extraction research of bovine brain PS, opened up new ways for the value-added utilization of bovine brain, and explored the successful industrial production of bovine brain PS extraction and preparation methods.
发明内容Contents of the invention
本发明的目的是提供一种以牛、羊、兔、马、驴等家畜动物脑为原料的工艺简单并适于工业化生产的提取磷脂酰丝氨酸的方法。The purpose of the present invention is to provide a method for extracting phosphatidylserine, which is simple in technology and suitable for industrial production, using the brains of cattle, sheep, rabbits, horses, donkeys and other livestock animals as raw materials.
本发明的目的可通过如下技术措施来实现The purpose of the present invention can be achieved through the following technical measures
a、先将干燥动物脑碎成颗粒,再向颗粒中加入丙酮,搅拌萃取,除去含有干脑粒中胆固醇和油类的丙酮上清液,残渣蒸干;a. First crush the dried animal brain into granules, then add acetone to the granules, stir and extract, remove the acetone supernatant containing cholesterol and oil in the dried brain granules, and evaporate the residue to dryness;
b、向蒸干的残渣加入正己烷或乙醇或氨水乙醇溶液,搅拌萃取,除去含有磷脂复合物的萃取液,残渣蒸干;b. Add n-hexane or ethanol or ammonia ethanol solution to the evaporated residue, stir and extract, remove the extract containing phospholipid complex, and evaporate the residue to dryness;
c、向蒸干的残渣加入乙醚,搅拌萃取,萃取液经蒸浓后加入碱性水溶液,搅拌、冻结、解冻,滤除沉淀,进一步除去剩余的磷脂,然后将上清液调PH=3~6,蒸除乙醚,再蒸干得粗磷脂酰丝氨酸。c. Add diethyl ether to the evaporated residue, stir and extract, add alkaline aqueous solution to the extract after evaporation, stir, freeze, thaw, filter out the precipitate, further remove the remaining phospholipids, and then adjust the supernatant to PH=3~ 6. Ether was evaporated, and then evaporated to dryness to obtain crude phosphatidylserine.
本发明的目的还可通过如下技术措施来实现The purpose of the present invention can also be realized by the following technical measures
将c工序中粗磷脂酰丝氨酸干粉溶于正己烷中,加入醋酸钠乙醇溶液,搅拌、静置分层,除去含有肌醇磷脂的下层,上部正己烷蒸干得高纯度磷脂酰丝氨酸;或者将c工序中蒸除乙醚后直接加入与剩余溶液大致同量的正己烷,搅拌、静置分层,除去含有肌醇磷脂的下层,上部正己烷蒸干得磷脂酰丝氨酸;前面所述的搅拌萃取为3~5次,每次1~3小时;所述的氨水乙醇溶液及碱性水溶液的PH=7.5~11;所述的解冻控制温度为4~7℃;所述的醋酸钠乙醇溶液是指含醋酸钠的40~60%乙醇。Dissolve the dry crude phosphatidylserine powder in step c in n-hexane, add sodium acetate ethanol solution, stir, let stand to separate layers, remove the lower layer containing inositol phospholipids, evaporate the upper part of n-hexane to dryness to obtain high-purity phosphatidylserine; or In step c, diethyl ether is distilled off, and n-hexane of approximately the same amount as the remaining solution is directly added, stirred, allowed to stand for stratification, and the lower layer containing inositol phospholipids is removed, and the upper part of n-hexane is evaporated to dryness to obtain phosphatidylserine; the aforementioned stirring extraction 3 to 5 times, 1 to 3 hours each time; the PH of the ammonia water ethanol solution and the alkaline aqueous solution is 7.5 to 11; the thawing control temperature is 4 to 7°C; the sodium acetate ethanol solution is Refers to 40-60% ethanol containing sodium acetate.
本发明的技术措施是先将干燥动物脑碎成大致为0.2~0.4cm的颗粒,再向颗粒中加入体积为3~5倍量的丙酮,搅拌萃取,除去含有干脑粒中胆固醇和油类。若抽提肌醇磷脂和PS磷脂复合物的溶剂为乙醚时,乙醚加入量为蒸干的残渣体积的3~5倍量,得乙醚提取液,可蒸去大部分乙醚使剩余的乙醚溶液体积为乙醚提取的干物质的3~5倍量。将该乙醚溶液加入到PH=7.5~11的Na2CO3水溶液中成盐,搅拌1小时,-10~20℃冻结,4~7℃缓慢解冻。除去下部沉淀,将上清液用2~5%HCl调PH=3~6。蒸除乙醚,蒸干水分得干粉;或蒸除乙醚后加入与剩余溶液同量的正己烷,搅拌分层,取上部正己烷层,蒸去正己烷得干物质。然后再向干物质加入3~5倍正己烷(或上述中最后加入的正己烷得到的上部正己烷层),再加入体积5~10倍干物质量含醋酸钠的40~60%乙醇液搅拌,静止分层,除去下部白色沉淀(主要为肌醇磷脂)取上部正己烷层,蒸干得磷脂酰丝氨酸,磷脂酰丝氨酸纯度为90~93%。The technical measure of the present invention is to first crush the dried animal brain into particles with a size of approximately 0.2-0.4 cm, then add acetone with a volume of 3-5 times the volume to the particles, stir and extract, and remove the cholesterol and oil contained in the dry brain particles . If the solvent for extracting inositol phospholipids and PS phospholipid complexes is diethyl ether, the amount of diethyl ether added is 3 to 5 times the volume of the evaporated residue to obtain a diethyl ether extract. Most of the diethyl ether can be evaporated to make the volume of the remaining diethyl ether solution 3 to 5 times the amount of dry matter extracted with ether. Add the ether solution to Na 2 CO 3 aqueous solution with pH=7.5-11 to form a salt, stir for 1 hour, freeze at -10-20°C, and slowly thaw at 4-7°C. The lower precipitate was removed, and the supernatant was adjusted to pH=3-6 with 2-5% HCl. Evaporate diethyl ether and evaporate water to obtain dry powder; or distill diethyl ether and add the same amount of n-hexane as the remaining solution, stir and separate layers, take the upper n-hexane layer, and distill off n-hexane to obtain dry matter. Then add 3 to 5 times of normal hexane (or the upper normal hexane layer obtained by the last added normal hexane in the above-mentioned) to the dry matter, then add 5 to 10 times of the dry matter by volume and stir in 40 to 60% ethanol solution containing sodium acetate, After static layering, remove the lower white precipitate (mainly inositol phospholipids), take the upper n-hexane layer, evaporate to dryness to obtain phosphatidylserine, and the purity of phosphatidylserine is 90-93%.
本发明的技术措施若抽提的肌醇磷脂和磷脂复合物的溶剂为正己烷,可将大部分正己烷蒸除,剩余正己烷溶液体积为正己烷提取干物质的3~5倍。然后先除去肌醇磷脂等杂质,再将正己烷蒸除,得干物质后溶于乙醚,最后蒸除乙醚,得磷脂酰丝氨酸,纯度为92~95%。If the solvent of the extracted inositol phospholipids and phospholipid complexes of the technical measures of the present invention is n-hexane, most of the n-hexane can be evaporated, and the volume of the remaining n-hexane solution is 3 to 5 times of the dry matter extracted by n-hexane. Impurities such as inositol phospholipids are then removed first, and then n-hexane is evaporated to obtain dry matter, which is then dissolved in ether, and finally ether is evaporated to obtain phosphatidylserine with a purity of 92-95%.
本发明的技术措施若用丙酮除去脑中胆固醇及油脂,干燥得干脑粒,再向干脑粒中加入体积为3~5倍量的正己烷,搅拌萃取3~5次,每次1~3小时,得正己烷提取液,蒸除含有脑总磷脂复合物的正己烷,经乙醚处理后再蒸干得粗磷脂酰丝氨酸,纯度为53%。采用此方案可节约使用大量乙醇。If the technical measure of the present invention removes cholesterol and grease in the brain with acetone, dry to obtain dry brain granules, then add normal hexane with a volume of 3 to 5 times the amount in the dry brain granules, stir and extract 3 to 5 times, each time 1 to 5 times. After 3 hours, the n-hexane extract was obtained, the n-hexane containing the total brain phospholipid complex was evaporated, treated with ether, and then evaporated to dryness to obtain crude phosphatidylserine with a purity of 53%. Adopting this scheme can save the use of a large amount of ethanol.
所述的氨水可用氢氧化钠、氢氧化钾、磷酸氢二钠、磷酸氢二钾、碳酸氢钠、碳酸氢钾、碳酸钠、碳酸钾、醋酸钠或醋酸钾替代,但效果以氨水为最好。所述的正己烷可用氯仿、二氯甲烷、甲苯、乙醚替代,一般以正己烷为优选,以减少有机溶剂使用的种类,减少有机溶剂回收塔的建设,简化生产工艺。The ammoniacal liquor can be replaced by sodium hydroxide, potassium hydroxide, disodium hydrogenphosphate, dipotassium hydrogenphosphate, sodium bicarbonate, potassium bicarbonate, sodium carbonate, potassium carbonate, sodium acetate or potassium acetate, but the effect is best with ammoniacal liquor. good. The n-hexane can be replaced by chloroform, methylene chloride, toluene, ether, and n-hexane is generally preferred to reduce the types of organic solvents used, reduce the construction of organic solvent recovery towers, and simplify the production process.
本发明选用常规的有机溶剂提取,可实现大规模工业化生产。脑粒用丙酮除去胆固醇及油类,用乙醇除去卵磷脂,脑磷脂,用正己烷、乙醚提取以磷脂酰丝氨酸和肌醇磷脂为主要成分的磷脂混合物,再用正己烷、碱乙醇溶剂除去沉下肌醇磷脂及杂质,得粗磷脂酰丝氨酸。粗磷脂酰丝氨酸溶于乙醚、该乙醚溶液加入碱性溶液中成盐,冷冻,解冻除沉淀,上清液调PH=3~6。正己烷搅拌提取,静置分层,得正己烷层,蒸去正己烷得高纯度磷脂酰丝氨酸。也可将提取的磷脂酰丝氨酸和肌醇磷脂磷脂复合物溶于乙醚,再溶于碱性水溶液冷冻除杂,然后再用正己烷、碱乙醇除肌醇磷脂,得高纯度磷脂酰丝氨酸。还可用正己烷提取除去胆固醇及油的脑颗粒得总磷脂复合物,其后操作同以磷脂酰丝氨酸和肌醇磷脂为主成分的磷脂复合物提取磷脂酰丝氨酸方法,但纯度较低。The present invention selects conventional organic solvent for extraction, and can realize large-scale industrialized production. Use acetone to remove cholesterol and oils, use ethanol to remove lecithin and cephalin, use n-hexane and ether to extract the phospholipid mixture with phosphatidylserine and inositol phospholipids as the main components, and then use n-hexane and alkali ethanol solvent to remove the precipitate Lower inositol phospholipids and impurities to obtain crude phosphatidylserine. Crude phosphatidylserine is dissolved in ether, and the ether solution is added to an alkaline solution to form a salt, frozen, thawed to remove precipitation, and the supernatant is adjusted to PH=3-6. Stir and extract with n-hexane, let stand to separate layers to obtain the n-hexane layer, evaporate the n-hexane to obtain high-purity phosphatidylserine. The extracted phosphatidylserine and inositol phospholipid complex can also be dissolved in ether, then dissolved in alkaline aqueous solution to freeze to remove impurities, and then use n-hexane and alkali ethanol to remove inositol phospholipids to obtain high-purity phosphatidylserine. It is also possible to use n-hexane to extract the brain particles that remove cholesterol and oil to obtain the total phospholipid complex, and then operate the same method for extracting phosphatidylserine from the phospholipid complex with phosphatidylserine and inositol phospholipids as the main components, but the purity is lower.
具体实施方式Detailed ways
实施例1Example 1
1、将鲜牛脑(或冷冻的牛脑)切片,60℃通风烘干,也可自然条件下晒干或晾干,干燥温度越低越好,低温干燥最好,碎成0.3cm左右的颗粒,向干燥的牛脑颗粒中加体积为4倍量的丙酮,常温搅拌萃取4次,每次2小时,除去丙酮上清液,残渣蒸至无丙酮味;1. Slice fresh bovine brain (or frozen bovine brain), ventilate and dry at 60°C, or dry in the sun or dry under natural conditions. The lower the drying temperature, the better, and the best low temperature drying, broken into pieces of about 0.3cm Granules, add acetone of 4 times the volume to the dried bovine brain granules, stir and extract 4 times at room temperature, each time for 2 hours, remove the acetone supernatant, and steam the residue until there is no acetone smell;
2、向蒸干的残渣内加入体积为4倍量的PH=9的氨水乙醇溶液,搅拌萃取4次,每次2小时,残渣蒸干,提取液可用于再提取卵磷脂和脑磷脂;2. Add 4 times the volume of ammonia-ethanol solution of pH=9 to the evaporated residue, stir and extract 4 times, each time for 2 hours, evaporate the residue, and the extract can be used to re-extract lecithin and cephalin;
3、向蒸干的残渣内加入乙醚,得乙醚提取液,过滤蒸除大部分乙醚,所剩乙醚溶液的体积为乙醚提取的干物质的4倍为止。将其加入到PH=8.5的Na2CO3水溶液中,搅拌1小时,-18℃冻结,6℃缓慢解冻。可见淡黄色上清液和下部沉淀,除沉淀后将上清液用4%HCl调PH=5,蒸干水分得干粉。3. Add ether to the evaporated residue to obtain an ether extract, filter and evaporate most of the ether until the volume of the remaining ether solution is 4 times that of the dry matter extracted with ether. Add it to Na 2 CO 3 aqueous solution with pH=8.5, stir for 1 hour, freeze at -18°C, and slowly thaw at 6°C. The light yellow supernatant and the lower part of the precipitate can be seen. After removing the precipitate, the supernatant was adjusted to pH=5 with 4% HCl, and evaporated to dryness to obtain a dry powder.
4、将干粉溶于体积为4倍量的正己烷中,再加入体积为8倍干粉量的含醋酸钠的50%乙醇,搅拌、静止分层,可见下面有白色沉淀(沉淀可用于提取肌醇磷脂)。然后将上部正己烷层移出,减压蒸干得磷脂酰丝氨酸,纯度为93%。4. Dissolve the dry powder in n-hexane with a volume 4 times the volume, then add 50% ethanol containing sodium acetate with a volume 8 times the volume of the dry powder, stir, and layer at rest. It can be seen that there is a white precipitate below (the precipitate can be used to extract muscle alcohol phospholipids). Then the upper n-hexane layer was removed and evaporated to dryness under reduced pressure to obtain phosphatidylserine with a purity of 93%.
实施例2Example 2
1、如果所用原料为鲜兔脑、羊脑、马脑、驴脑等家畜动物脑,脑的干燥方法同牛脑,如果所用原料为提取过胆固醇后的干脑颗粒,可直接按实施例1中2开始做,下同。1. If the raw materials used are fresh rabbit brains, sheep brains, horse brains, donkey brains and other livestock animal brains, the drying method of the brains is the same as that of cow brains. If the raw materials used are the dried brain particles after extracting cholesterol, it can be directly carried out according to Example 1. Start from middle 2, the same below.
实施例3Example 3
实施例1中步骤2,向蒸干的残渣中加入氨水乙醇溶液,是为了除去脑渣中含有的卵磷脂和脑磷脂。In step 2 of Example 1, adding ammonia water ethanol solution to the evaporated residue is to remove the lecithin and cephalin contained in the brain residue.
该步骤也可先向脑渣内加入体积为4倍量的无水乙醇,搅拌萃取4小时,提取4次,每次2小时,可提取含约50%卵磷脂,也含约25%的脑磷脂及其他磷脂类,但主成分是卵磷脂,有利于卵磷脂的进一步纯化。然后再用渣4倍量PH=9的氨水乙醇提取,搅拌萃取4次,每次2小时,干后的提取物中含脑磷脂在60%左右,也含有10%卵磷脂及其他磷脂,但主成分是脑磷脂,利于脑磷脂的进一步分离,其他步骤同实施例1。In this step, dehydrated alcohol with a volume of 4 times the volume can also be added to the brain slag, stirred and extracted for 4 hours, extracted 4 times, each time for 2 hours, and about 50% lecithin and about 25% brain can be extracted. Phospholipids and other phospholipids, but the main component is lecithin, which is conducive to the further purification of lecithin. Then use 4 times the amount of slag to extract with ammonia ethanol of PH=9, stir and extract 4 times, each 2 hours, contain cephalin in about 60% in the extract after drying, also contain 10% lecithin and other phospholipids, but The main component is cephalin, which is beneficial to the further separation of cephalin, and other steps are the same as in Example 1.
实施例4Example 4
实施例1中步骤3,向蒸干的残渣加入4倍量的乙醚提取,乙醚也可用正己烷、甲苯或氯仿、二氯甲烷替代,提取方法同乙醚,但将提取物加入Na2CO3水溶液时,必须先将正己烷等(甲苯、氯仿、二氯甲烷)蒸发掉,然后用3倍乙醚溶解,再加入Na2CO3碱液,其他步骤同实施例1。In step 3 of Example 1, add 4 times the amount of diethyl ether to the evaporated residue for extraction. Diethyl ether can also be replaced by n-hexane, toluene, chloroform, or dichloromethane. The extraction method is the same as diethyl ether, but the extract is added to Na 2 CO 3 aqueous solution In this case, normal hexane etc. (toluene, chloroform, dichloromethane) must be evaporated first, then dissolved with 3 times ether, and then Na 2 CO 3 lye is added, other steps are the same as in Example 1.
实施例5Example 5
如实施例1步骤3中用正己烷提取而不用乙醚提取,可将正己烷提取液浓缩,所剩的正己烷溶液的体积为其所提取的干物质的4倍量,然后加入体积为7倍干物质量的含醋酸钠的45%乙醇、搅拌、静止、分层、除去白色的肌醇磷脂沉淀。移出正己烷层,蒸除正己烷得干粉,干粉用体积为4倍量乙醚溶解,加入PH=8的Na2CO3水溶液,搅拌1小时,-15℃冻结,6℃缓慢解冻,得上清液,用3%HCl调PH=5,蒸发回收乙醚后,蒸干水分得磷脂酰丝氨酸干粉。最好在蒸发回收乙醚后,向剩余水溶液内加入正己烷,搅拌,静止得正己烷层,蒸除正己烷,磷脂酰丝氨酸纯度为94%。As in step 3 of Example 1, extract with n-hexane instead of diethyl ether, the n-hexane extract can be concentrated, and the volume of the remaining n-hexane solution is 4 times the amount of the extracted dry matter, and then add the volume to 7 times 45% ethanol containing sodium acetate in the amount of dry matter, stirred, static, layered, and the white inositol phospholipid precipitate was removed. Remove the n-hexane layer, distill off the n-hexane to obtain a dry powder, dissolve the dry powder with 4 times the volume of ether, add a Na 2 CO 3 aqueous solution with a pH of 8, stir for 1 hour, freeze at -15°C, and slowly thaw at 6°C to obtain a supernatant solution, adjust the pH to 5 with 3% HCl, evaporate and recover ether, and evaporate the water to obtain dry phosphatidylserine powder. Preferably, after recovery of ether by evaporation, add n-hexane to the remaining aqueous solution, stir, and stand still to obtain the n-hexane layer, then evaporate the n-hexane, and the purity of phosphatidylserine is 94%.
实施例6Example 6
1、如实施例1步骤1丙酮抽提胆固醇及油类的方法,向丙酮抽提过的干脑粒中加入4倍量的正己烷(正己烷可用乙醚、二氯甲烷、氯仿、甲苯取代),4次抽提,每次抽提2小时,可得正己烷溶液,蒸除正己烷可得脑中总磷脂复合物。1, as the method for extracting cholesterol and oils with acetone in step 1 of embodiment 1, add 4 times of normal hexane (normal hexane can be replaced by ether, methylene dichloride, chloroform, toluene) in the dried brain granules extracted by acetone , 4 times of extraction, each extraction for 2 hours, can obtain n-hexane solution, and evaporate n-hexane to obtain the total phospholipid complex in the brain.
2、如实施例1中步骤3,上述抽提的总磷脂复合物溶解于乙醚,以下操作如实施例1中步骤3。缓慢解冻后,可除去大量卵磷脂、脑磷脂沉淀,上清液调PH=6蒸除乙醚后,蒸干水分得粗PS干粉,干粉磷脂酰丝氨酸含量达53%。2. As in step 3 in Example 1, the total phospholipid complex extracted above was dissolved in ether, and the following operations were as in step 3 in Example 1. After slow thawing, a large amount of lecithin and cephalin precipitates can be removed. After the supernatant is adjusted to PH=6 and diethyl ether is evaporated, the water is evaporated to obtain crude PS dry powder. The content of phosphatidylserine in the dry powder reaches 53%.
3、上述粗PS干粉按实施例1中4操作可得粗磷脂酰丝氨酸,纯度达84%。3. The above crude PS dry powder was operated according to 4 in Example 1 to obtain crude phosphatidylserine with a purity of 84%.
Claims (7)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100242257A CN1308334C (en) | 2004-06-01 | 2004-06-01 | Extraction of phosphatidyl serine from brains of animals |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100242257A CN1308334C (en) | 2004-06-01 | 2004-06-01 | Extraction of phosphatidyl serine from brains of animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1583766A CN1583766A (en) | 2005-02-23 |
| CN1308334C true CN1308334C (en) | 2007-04-04 |
Family
ID=34600836
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100242257A Expired - Fee Related CN1308334C (en) | 2004-06-01 | 2004-06-01 | Extraction of phosphatidyl serine from brains of animals |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1308334C (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102559371B (en) * | 2012-02-21 | 2013-09-18 | 山东师范大学 | Method for preparing phosphatidylserine-enriched krill oil |
| CN102964379B (en) * | 2012-11-16 | 2015-10-21 | 成都圆大生物科技有限公司 | A kind of method preparing phosphatidylserine and phosphatidylcholine |
| CN103262893B (en) * | 2013-06-13 | 2014-11-05 | 俞祖勋 | Formula milk powder capable of improving intelligence |
| CN107259041A (en) * | 2017-06-12 | 2017-10-20 | 芜湖福民生物药业股份有限公司 | Phosphatidylserine pressed candy and preparation method thereof |
| CN107242574A (en) * | 2017-06-12 | 2017-10-13 | 芜湖福民生物药业股份有限公司 | Electuary containing phosphatidylserine and preparation method thereof |
| IT202100032252A1 (en) * | 2021-12-22 | 2023-06-22 | Fidia Farm Spa | Industrial extraction and purification process of phospholipids |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595680A (en) * | 1983-11-17 | 1986-06-17 | Fidia, S.P.A. | Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation |
| US5700668A (en) * | 1995-12-08 | 1997-12-23 | Italfarmaco Sud S.P.A. | Process for the industrial preparation of phosphatidylserine |
-
2004
- 2004-06-01 CN CNB2004100242257A patent/CN1308334C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4595680A (en) * | 1983-11-17 | 1986-06-17 | Fidia, S.P.A. | Pharmaceutical compositions and method for preparing phosphatidylserine compositions useful in treating central nervous system disorders without effects on blood coagulation |
| US5700668A (en) * | 1995-12-08 | 1997-12-23 | Italfarmaco Sud S.P.A. | Process for the industrial preparation of phosphatidylserine |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1583766A (en) | 2005-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8568819B2 (en) | Solid composition containing lipids from crustaceans | |
| CN1308334C (en) | Extraction of phosphatidyl serine from brains of animals | |
| CN103320217A (en) | Method for extracting krill oil rich in phospholipid from euphausia superba | |
| CN102633832A (en) | Method for preparing high-purity phosphatidylcholine | |
| JPH08511547A (en) | Method for obtaining highly purified phosphatidylcholine | |
| CN102924506A (en) | Preparation method of high-purity lecithin | |
| CN102181321A (en) | Method for preparing oil by low aqueous enzymatic method and organic solvent extraction | |
| CN1451729A (en) | Method for extracting yolk oil by enzyme hydrolysis-solvent extraction | |
| CN1234723C (en) | Method for extracting fucosterol from alga | |
| JP2009227765A (en) | Manufacturing method of plasmalogen containing lipid | |
| JP2004026767A (en) | Method for producing phospholipids derived from seafood | |
| CN104262388A (en) | Preparation process of high-purity phosphatidylcholine | |
| CN101028509B (en) | Snake gallbladder for artificial medicine | |
| RU2274460C2 (en) | Cerebroside-cerebroside sulfate-containing lipid complex and method for its preparing | |
| CN101028510B (en) | Snake gallbladder for artificial medicine and its production | |
| RU2833272C2 (en) | Method of producing bilirubin | |
| JP4858828B2 (en) | Methods for removing heavy metals from animal tissues or organs | |
| KR100699047B1 (en) | Calcium bound peptide preparation method | |
| RU2717529C1 (en) | Method of processing biological material | |
| JPH03273096A (en) | Method for extraction of lipid mixture | |
| Kartushina et al. | Technological desition of extraction of melanin from the waste of production of sunflower-seed oil | |
| CN1733776A (en) | A kind of preparation method of high-purity egg yolk cephalin | |
| CA2698642A1 (en) | Production of fatty acid and fatty acid ester | |
| JP3845754B2 (en) | Method for producing liver oil | |
| CN119320406A (en) | Preparation method of phosphatidylserine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |